Published online May 21, 2017. doi: 10.3748/wjg.v23.i19.3530
Peer-review started: December 29, 2017
First decision: March 3, 2017
Revised: March 14, 2017
Accepted: May 4, 2017
Article in press: May 4, 2017
Published online: May 21, 2017
Processing time: 142 Days and 23.2 Hours
To evaluate the short health scale (SHS), a new, simple, four-part visual analogue scale questionnaire that is designed to assess the impact of inflammatory bowel disease (IBD) on health-related quality of life (HRQOL), in Korean-speaking patients with IBD.
The SHS was completed by 256 patients with Crohn’s disease (CD) and ulcerative colitis (UC). Individual SHS items were correlated with inflammatory bowel disease questionnaire (IBDQ) dimensions and with disease activity to assess validity. Test-retest reliability, responsiveness and patient or disease characteristics with probable association with high SHS scores were analyzed.
Of 256 patients with IBD, 139 (54.3%) had UC and 117 (45.7%) had CD. The correlation coefficients between SHS questions about “symptom burden”, “activities of daily living”, and “disease-related worry” and their corresponding dimensions in the IBDQ ranged from 0.62 to 0.71, compared with correlation coefficients ranging from -0.45 to -0.61 for their non-corresponding dimensions. There was a stepwise increase in SHS scores, with increasing disease activity in both CD and UC (all P values < 0.001). Reliability was confirmed with test-retest correlations ranging from 0.68 to 0.90 (all P values < 0.001). Responsiveness was confirmed with the patients who remained in remission. Their SHS scores remained unchanged, except for the SHS dimension “disease-related worry”. In the multivariate analysis, female sex was associated with worse “general well-being” (OR = 2.28, 95%CI: 1.02-5.08) along with worse disease activity.
The SHS is a valid and reliable measure of HRQOL in Korean-speaking patients with IBD.
Core tip: The short health scale (SHS) is a new, simple, four-part visual analog scale questionnaire that is designed to assess the impact of inflammatory bowel disease (IBD) on health-related quality of life (HRQOL). In Korean-speaking IBD patients, total SHS scores correlated with total IBDQ scores in both Crohn’s disease (CD) and ulcerative colitis (UC). There was a stepwise increase in SHS scores with increasing disease activity in both CD and UC. Reliability was confirmed with test-retest correlations. Thus, SHS is a valid and reliable measure of HRQOL in Korean-speaking patients with IBD.